Theravance Biopharma TBPH Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's tax on share settlement?
- Theravance Biopharma (TBPH) reported tax on share settlement of $5.82M in Q1 2026.
- How has Theravance Biopharma's tax on share settlement changed year-over-year?
- Theravance Biopharma's tax on share settlement increased by 565.7% year-over-year, from $874K to $5.82M.
- What is the long-term trend for Theravance Biopharma's tax on share settlement?
- Over 4 years (2021 to 2025), Theravance Biopharma's tax on share settlement has grown at a -18.3% compound annual growth rate (CAGR), from $9.06M to $4.03M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.